Resultados de la búsqueda 361-370 of 9188 for Drug-resistant TB

1. Bispecific antibody therapy

   Several bispecific antibody therapies have been approved by the U.S. Food and Drug Administration (FDA). Most are used to treat blood cancers and cancers of the ...

2. Mayo Clinic Digestive Diseases Physician Update - September 2023

   Page 1.

3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... resistant chronic lymphocytic leukemia. Patients ... Patients randomized to B+R will receive 6 cycles of treatment consisting of ... A Study of Leukemia Inhibitory ...

4. Hematología - Ensayos clínicos - Mayo Clinic

   ... Resistant To Current Standard Of Care Treatments. Rochester, Minn. This phase 1b trial is an open-label study designed to assess the safety, tolerability ...

5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... Resistant to Current Standard of Care Treatments. Rochester, Minn. This phase 1b trial is an open-label study designed to assess the safety, tolerability ...

6. Hematología - Ensayos clínicos - Mayo Clinic

   ... Resistant To Current Standard Of Care Treatments. Rochester, Minn. This phase 1b trial is an open-label study designed to assess the safety, tolerability ...

7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... Resistant To Current Standard Of Care Treatments. Rochester, Minn. This phase 1b trial is an open-label study designed to assess the safety, tolerability ...

8. Metastatic (stage 4) breast cancer - Diagnósticos y tratamientos - Mayo Clinic

   This test looks for tiny pieces of DNA from cancer cells in the blood. Results can help the healthcare team choose a treatment. Imaging tests. Imaging tests ...

9. Hematología - Ensayos clínicos - Mayo Clinic

   ... Resistant To Current Standard Of Care Treatments. Rochester, Minn. This phase 1b trial is an open-label study designed to assess the safety, tolerability ...

10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ABBV-383 is an investigational drug being developed for the treatment ... Resistant to Current Standard of Care Treatments. Rochester, Minn. This phase ...